Lilly's $5B Bet: Pharma Manufacturing Returns to the US

Eli Lilly is betting big on American manufacturing, investing $5 billion in a Virginia plant to boost domestic drug production for cancer and autoimmune diseases. Fueled by potential tariffs and a push for supply chain security, this move will create hundreds of jobs and marks a major shift in the pharmaceutical industry, with three more U.S. factories on the horizon. Hosted on Acast. See acast.com/privacy for more information.